APO Research
Talk to an analyst

APO RESEARCH · REPORT

In Vitro Diagnostic Devices

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global In Vitro Diagnostic Devices Market Outlook and Growth Opportunities 2026

30 December 2025210 pages

Choose your research edition.

Industry ResearchIn Vitro Diagnostic Devices Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal In Vitro Diagnostic Devices Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal In Vitro Diagnostic Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In Vitro Diagnostic Devices Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal In Vitro Diagnostic Devices Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global In Vitro Diagnostic Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for In Vitro Diagnostic Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for In Vitro Diagnostic Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In Vitro Diagnostic Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the In Vitro Diagnostic Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the In Vitro Diagnostic Devices market include Abbott, Thermo Fisher Scientific, Roche, Wondfo, Sysmex, Siemens Healthineers, Qiagen, Ortho Clinical Diagnostics and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global In Vitro Diagnostic Devices market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In Vitro Diagnostic Devices and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In Vitro Diagnostic Devices revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global In Vitro Diagnostic Devices market.

In Vitro Diagnostic Devices Segment by Company

Abbott

Thermo Fisher Scientific

Roche

Wondfo

Sysmex

Siemens Healthineers

Qiagen

Ortho Clinical Diagnostics

Myriad Genetics

Mindray

LG Chem

Leadman Biochemistry

KHB

Johnson and Johnson

Hologic

Danaher

DAAN Gene

BioSino

Bio-Rad Laboratories

Biomerieux

Becton Dickinson

In Vitro Diagnostic Devices Segment by Type

POCT

Molecular Diagnostics

Chemistry Diagnostics

Immuno Diagnostics

Other

In Vitro Diagnostic Devices Segment by Application

Hospitals

Laboratory

Other

In Vitro Diagnostic Devices Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global In Vitro Diagnostic Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the In Vitro Diagnostic Devices key companies, revenue, market share, and recent developments.

3. To split the In Vitro Diagnostic Devices breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions In Vitro Diagnostic Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify In Vitro Diagnostic Devices significant trends, drivers, influence factors in global and regions.

6. To analyze In Vitro Diagnostic Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Diagnostic Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vitro Diagnostic Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Diagnostic Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vitro Diagnostic Devices industry.

Chapter 3: Detailed analysis of In Vitro Diagnostic Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of In Vitro Diagnostic Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of In Vitro Diagnostic Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. In Vitro Diagnostic Devices Industry Trends Table 2. In Vitro Diagnostic Devices Industry Drivers Table 3. In Vitro Diagnostic Devices Industry Opportunities and Challenges Table 4. In Vitro Diagnostic Devices Industry Restraints Table 5. Global In Vitro Diagnostic Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global In Vitro Diagnostic Devices Revenue Share by Company (2021-2026) Table 7. Global In Vitro Diagnostic Devices Company Ranking, (2024-2026) & (US$ Million) Table 8. Global In Vitro Diagnostic Devices Key Company Manufacturing Base & Headquarters Table 9. Global In Vitro Diagnostic Devices Company, Product Type & Application Table 10. Global In Vitro Diagnostic Devices Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global In Vitro Diagnostic Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of POCT Table 15. Significant Companies of Molecular Diagnostics Table 16. Significant Companies of Chemistry Diagnostics Table 17. Significant Companies of Immuno Diagnostics Table 18. Significant Companies of Other Table 19. Global In Vitro Diagnostic Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global In Vitro Diagnostic Devices Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global In Vitro Diagnostic Devices Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global In Vitro Diagnostic Devices Sales Value Share by Type (2021-2026) Table 23. Global In Vitro Diagnostic Devices Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Laboratory Table 26. Significant Companies of Other Table 27. Global In Vitro Diagnostic Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global In Vitro Diagnostic Devices Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global In Vitro Diagnostic Devices Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global In Vitro Diagnostic Devices Sales Value Share by Application (2021-2026) Table 31. Global In Vitro Diagnostic Devices Sales Value Share by Application (2027-2032) Table 32. Global In Vitro Diagnostic Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global In Vitro Diagnostic Devices Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global In Vitro Diagnostic Devices Sales Value Share by Region (2021-2026) Table 35. Global In Vitro Diagnostic Devices Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global In Vitro Diagnostic Devices Sales Value Share by Region (2027-2032) Table 37. Global In Vitro Diagnostic Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global In Vitro Diagnostic Devices Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global In Vitro Diagnostic Devices Sales Value Market Share by Country (2021-2026) Table 40. Global In Vitro Diagnostic Devices Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global In Vitro Diagnostic Devices Sales Value Market Share by Country (2027-2032) Table 42. Abbott Company Information Table 43. Abbott Business Overview Table 44. Abbott In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Abbott In Vitro Diagnostic Devices Product Portfolio Table 46. Abbott Recent Development Table 47. Thermo Fisher Scientific Company Information Table 48. Thermo Fisher Scientific Business Overview Table 49. Thermo Fisher Scientific In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio Table 51. Thermo Fisher Scientific Recent Development Table 52. Roche Company Information Table 53. Roche Business Overview Table 54. Roche In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Roche In Vitro Diagnostic Devices Product Portfolio Table 56. Roche Recent Development Table 57. Wondfo Company Information Table 58. Wondfo Business Overview Table 59. Wondfo In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Wondfo In Vitro Diagnostic Devices Product Portfolio Table 61. Wondfo Recent Development Table 62. Sysmex Company Information Table 63. Sysmex Business Overview Table 64. Sysmex In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Sysmex In Vitro Diagnostic Devices Product Portfolio Table 66. Sysmex Recent Development Table 67. Siemens Healthineers Company Information Table 68. Siemens Healthineers Business Overview Table 69. Siemens Healthineers In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio Table 71. Siemens Healthineers Recent Development Table 72. Qiagen Company Information Table 73. Qiagen Business Overview Table 74. Qiagen In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Qiagen In Vitro Diagnostic Devices Product Portfolio Table 76. Qiagen Recent Development Table 77. Ortho Clinical Diagnostics Company Information Table 78. Ortho Clinical Diagnostics Business Overview Table 79. Ortho Clinical Diagnostics In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio Table 81. Ortho Clinical Diagnostics Recent Development Table 82. Myriad Genetics Company Information Table 83. Myriad Genetics Business Overview Table 84. Myriad Genetics In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Myriad Genetics In Vitro Diagnostic Devices Product Portfolio Table 86. Myriad Genetics Recent Development Table 87. Mindray Company Information Table 88. Mindray Business Overview Table 89. Mindray In Vitro Diagnostic Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Mindray In Vitro Diagnostic Devices Product Portfolio Table 91. Mindray Recent Development Table 92. LG Chem Company Information Table 93. LG Chem Business Overview Table 94. LG Chem In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. LG Chem In Vitro Diagnostic Devices Product Portfolio Table 96. LG Chem Recent Development Table 97. Leadman Biochemistry Company Information Table 98. Leadman Biochemistry Business Overview Table 99. Leadman Biochemistry In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio Table 101. Leadman Biochemistry Recent Development Table 102. KHB Company Information Table 103. KHB Business Overview Table 104. KHB In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. KHB In Vitro Diagnostic Devices Product Portfolio Table 106. KHB Recent Development Table 107. Johnson and Johnson Company Information Table 108. Johnson and Johnson Business Overview Table 109. Johnson and Johnson In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio Table 111. Johnson and Johnson Recent Development Table 112. Hologic Company Information Table 113. Hologic Business Overview Table 114. Hologic In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Hologic In Vitro Diagnostic Devices Product Portfolio Table 116. Hologic Recent Development Table 117. Danaher Company Information Table 118. Danaher Business Overview Table 119. Danaher In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Danaher In Vitro Diagnostic Devices Product Portfolio Table 121. Danaher Recent Development Table 122. DAAN Gene Company Information Table 123. DAAN Gene Business Overview Table 124. DAAN Gene In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. DAAN Gene In Vitro Diagnostic Devices Product Portfolio Table 126. DAAN Gene Recent Development Table 127. BioSino Company Information Table 128. BioSino Business Overview Table 129. BioSino In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. BioSino In Vitro Diagnostic Devices Product Portfolio Table 131. BioSino Recent Development Table 132. Bio-Rad Laboratories Company Information Table 133. Bio-Rad Laboratories Business Overview Table 134. Bio-Rad Laboratories In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio Table 136. Bio-Rad Laboratories Recent Development Table 137. Biomerieux Company Information Table 138. Biomerieux Business Overview Table 139. Biomerieux In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Biomerieux In Vitro Diagnostic Devices Product Portfolio Table 141. Biomerieux Recent Development Table 142. Becton Dickinson Company Information Table 143. Becton Dickinson Business Overview Table 144. Becton Dickinson In Vitro Diagnostic Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Becton Dickinson In Vitro Diagnostic Devices Product Portfolio Table 146. Becton Dickinson Recent Development Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. In Vitro Diagnostic Devices Product Image Figure 2. Global In Vitro Diagnostic Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global In Vitro Diagnostic Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global In Vitro Diagnostic Devices Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. POCT Image Figure 8. Molecular Diagnostics Image Figure 9. Chemistry Diagnostics Image Figure 10. Immuno Diagnostics Image Figure 11. Other Image Figure 12. Global In Vitro Diagnostic Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global In Vitro Diagnostic Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global In Vitro Diagnostic Devices Sales Value Share by Type (2021-2032) Figure 15. Hospitals Image Figure 16. Laboratory Image Figure 17. Other Image Figure 18. Global In Vitro Diagnostic Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global In Vitro Diagnostic Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global In Vitro Diagnostic Devices Sales Value Share by Application (2021-2032) Figure 21. Global In Vitro Diagnostic Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global In Vitro Diagnostic Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America In Vitro Diagnostic Devices Sales Value (2021-2032) & (US$ Million) Figure 24. North America In Vitro Diagnostic Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe In Vitro Diagnostic Devices Sales Value (2021-2032) & (US$ Million) Figure 26. Europe In Vitro Diagnostic Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific In Vitro Diagnostic Devices Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific In Vitro Diagnostic Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America In Vitro Diagnostic Devices Sales Value (2021-2032) & (US$ Million) Figure 30. South America In Vitro Diagnostic Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa In Vitro Diagnostic Devices Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa In Vitro Diagnostic Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • POCT
  • Molecular Diagnostics
  • Chemistry Diagnostics
  • Immuno Diagnostics
  • Other
Applications
  • Hospitals
  • Laboratory
  • Other
Companies covered
  • Abbott
  • Thermo Fisher Scientific
  • Roche
  • Wondfo
  • Sysmex
  • Siemens Healthineers
  • Qiagen
  • Ortho Clinical Diagnostics
  • Myriad Genetics
  • Mindray
  • LG Chem
  • Leadman Biochemistry
  • KHB
  • Johnson and Johnson
  • Hologic
  • Danaher
  • DAAN Gene
  • BioSino
  • Bio-Rad Laboratories
  • Biomerieux
  • Becton Dickinson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global In Vitro Diagnostic Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global In Vitro Diagnostic Devices Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 In Vitro Diagnostic Devices Market Dynamics
  1. 2.1 In Vitro Diagnostic Devices Industry Trends
  2. 2.2 In Vitro Diagnostic Devices Industry Drivers
  3. 2.3 In Vitro Diagnostic Devices Industry Opportunities and Challenges
  4. 2.4 In Vitro Diagnostic Devices Industry Restraints
3 In Vitro Diagnostic Devices Market by Company
  1. 3.1 Global In Vitro Diagnostic Devices Company Revenue Ranking in 2025
  2. 3.2 Global In Vitro Diagnostic Devices Revenue by Company (2021-2026)
  3. 3.3 Global In Vitro Diagnostic Devices Company Ranking (2024-2026)
  4. 3.4 Global In Vitro Diagnostic Devices Company Manufacturing Base and Headquarters
  5. 3.5 Global In Vitro Diagnostic Devices Company Product Type and Application
  6. 3.6 Global In Vitro Diagnostic Devices Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global In Vitro Diagnostic Devices Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 In Vitro Diagnostic Devices Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 In Vitro Diagnostic Devices Market by Type
  1. 4.1 In Vitro Diagnostic Devices Type Introduction
  2. 4.1.1 POCT
  3. 4.1.2 Molecular Diagnostics
  4. 4.1.3 Chemistry Diagnostics
  5. 4.1.4 Immuno Diagnostics
  6. 4.1.5 Other
  7. 4.2 Global In Vitro Diagnostic Devices Sales Value by Type
  8. 4.2.1 Global In Vitro Diagnostic Devices Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global In Vitro Diagnostic Devices Sales Value by Type (2021-2032)
  10. 4.2.3 Global In Vitro Diagnostic Devices Sales Value Share by Type (2021-2032)
5 In Vitro Diagnostic Devices Market by Application
  1. 5.1 In Vitro Diagnostic Devices Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Laboratory
  4. 5.1.3 Other
  5. 5.2 Global In Vitro Diagnostic Devices Sales Value by Application
  6. 5.2.1 Global In Vitro Diagnostic Devices Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global In Vitro Diagnostic Devices Sales Value by Application (2021-2032)
  8. 5.2.3 Global In Vitro Diagnostic Devices Sales Value Share by Application (2021-2032)
6 In Vitro Diagnostic Devices Regional Value Analysis
  1. 6.1 Global In Vitro Diagnostic Devices Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global In Vitro Diagnostic Devices Sales Value by Region (2021-2032)
  3. 6.2.1 Global In Vitro Diagnostic Devices Sales Value by Region: 2021-2026
  4. 6.2.2 Global In Vitro Diagnostic Devices Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America In Vitro Diagnostic Devices Sales Value (2021-2032)
  7. 6.3.2 North America In Vitro Diagnostic Devices Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe In Vitro Diagnostic Devices Sales Value (2021-2032)
  10. 6.4.2 Europe In Vitro Diagnostic Devices Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific In Vitro Diagnostic Devices Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific In Vitro Diagnostic Devices Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America In Vitro Diagnostic Devices Sales Value (2021-2032)
  16. 6.6.2 South America In Vitro Diagnostic Devices Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa In Vitro Diagnostic Devices Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa In Vitro Diagnostic Devices Sales Value Share by Country, 2025 VS 2032
7 In Vitro Diagnostic Devices Country-level Value Analysis
  1. 7.1 Global In Vitro Diagnostic Devices Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global In Vitro Diagnostic Devices Sales Value by Country (2021-2032)
  3. 7.2.1 Global In Vitro Diagnostic Devices Sales Value by Country (2021-2026)
  4. 7.2.2 Global In Vitro Diagnostic Devices Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt In Vitro Diagnostic Devices Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt In Vitro Diagnostic Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt In Vitro Diagnostic Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott In Vitro Diagnostic Devices Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific In Vitro Diagnostic Devices Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche In Vitro Diagnostic Devices Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Wondfo
  20. 8.4.1 Wondfo Company Information
  21. 8.4.2 Wondfo Business Overview
  22. 8.4.3 Wondfo In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wondfo In Vitro Diagnostic Devices Product Portfolio
  24. 8.4.5 Wondfo Recent Developments
  25. 8.5 Sysmex
  26. 8.5.1 Sysmex Company Information
  27. 8.5.2 Sysmex Business Overview
  28. 8.5.3 Sysmex In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sysmex In Vitro Diagnostic Devices Product Portfolio
  30. 8.5.5 Sysmex Recent Developments
  31. 8.6 Siemens Healthineers
  32. 8.6.1 Siemens Healthineers Company Information
  33. 8.6.2 Siemens Healthineers Business Overview
  34. 8.6.3 Siemens Healthineers In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Siemens Healthineers In Vitro Diagnostic Devices Product Portfolio
  36. 8.6.5 Siemens Healthineers Recent Developments
  37. 8.7 Qiagen
  38. 8.7.1 Qiagen Company Information
  39. 8.7.2 Qiagen Business Overview
  40. 8.7.3 Qiagen In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Qiagen In Vitro Diagnostic Devices Product Portfolio
  42. 8.7.5 Qiagen Recent Developments
  43. 8.8 Ortho Clinical Diagnostics
  44. 8.8.1 Ortho Clinical Diagnostics Company Information
  45. 8.8.2 Ortho Clinical Diagnostics Business Overview
  46. 8.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Product Portfolio
  48. 8.8.5 Ortho Clinical Diagnostics Recent Developments
  49. 8.9 Myriad Genetics
  50. 8.9.1 Myriad Genetics Company Information
  51. 8.9.2 Myriad Genetics Business Overview
  52. 8.9.3 Myriad Genetics In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Myriad Genetics In Vitro Diagnostic Devices Product Portfolio
  54. 8.9.5 Myriad Genetics Recent Developments
  55. 8.10 Mindray
  56. 8.10.1 Mindray Company Information
  57. 8.10.2 Mindray Business Overview
  58. 8.10.3 Mindray In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mindray In Vitro Diagnostic Devices Product Portfolio
  60. 8.10.5 Mindray Recent Developments
  61. 8.11 LG Chem
  62. 8.11.1 LG Chem Company Information
  63. 8.11.2 LG Chem Business Overview
  64. 8.11.3 LG Chem In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  65. 8.11.4 LG Chem In Vitro Diagnostic Devices Product Portfolio
  66. 8.11.5 LG Chem Recent Developments
  67. 8.12 Leadman Biochemistry
  68. 8.12.1 Leadman Biochemistry Company Information
  69. 8.12.2 Leadman Biochemistry Business Overview
  70. 8.12.3 Leadman Biochemistry In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Leadman Biochemistry In Vitro Diagnostic Devices Product Portfolio
  72. 8.12.5 Leadman Biochemistry Recent Developments
  73. 8.13 KHB
  74. 8.13.1 KHB Company Information
  75. 8.13.2 KHB Business Overview
  76. 8.13.3 KHB In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  77. 8.13.4 KHB In Vitro Diagnostic Devices Product Portfolio
  78. 8.13.5 KHB Recent Developments
  79. 8.14 Johnson and Johnson
  80. 8.14.1 Johnson and Johnson Company Information
  81. 8.14.2 Johnson and Johnson Business Overview
  82. 8.14.3 Johnson and Johnson In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Johnson and Johnson In Vitro Diagnostic Devices Product Portfolio
  84. 8.14.5 Johnson and Johnson Recent Developments
  85. 8.15 Hologic
  86. 8.15.1 Hologic Company Information
  87. 8.15.2 Hologic Business Overview
  88. 8.15.3 Hologic In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hologic In Vitro Diagnostic Devices Product Portfolio
  90. 8.15.5 Hologic Recent Developments
  91. 8.16 Danaher
  92. 8.16.1 Danaher Company Information
  93. 8.16.2 Danaher Business Overview
  94. 8.16.3 Danaher In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Danaher In Vitro Diagnostic Devices Product Portfolio
  96. 8.16.5 Danaher Recent Developments
  97. 8.17 DAAN Gene
  98. 8.17.1 DAAN Gene Company Information
  99. 8.17.2 DAAN Gene Business Overview
  100. 8.17.3 DAAN Gene In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  101. 8.17.4 DAAN Gene In Vitro Diagnostic Devices Product Portfolio
  102. 8.17.5 DAAN Gene Recent Developments
  103. 8.18 BioSino
  104. 8.18.1 BioSino Company Information
  105. 8.18.2 BioSino Business Overview
  106. 8.18.3 BioSino In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BioSino In Vitro Diagnostic Devices Product Portfolio
  108. 8.18.5 BioSino Recent Developments
  109. 8.19 Bio-Rad Laboratories
  110. 8.19.1 Bio-Rad Laboratories Company Information
  111. 8.19.2 Bio-Rad Laboratories Business Overview
  112. 8.19.3 Bio-Rad Laboratories In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bio-Rad Laboratories In Vitro Diagnostic Devices Product Portfolio
  114. 8.19.5 Bio-Rad Laboratories Recent Developments
  115. 8.20 Biomerieux
  116. 8.20.1 Biomerieux Company Information
  117. 8.20.2 Biomerieux Business Overview
  118. 8.20.3 Biomerieux In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Biomerieux In Vitro Diagnostic Devices Product Portfolio
  120. 8.20.5 Biomerieux Recent Developments
  121. 8.21 Becton Dickinson
  122. 8.21.1 Becton Dickinson Company Information
  123. 8.21.2 Becton Dickinson Business Overview
  124. 8.21.3 Becton Dickinson In Vitro Diagnostic Devices Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Becton Dickinson In Vitro Diagnostic Devices Product Portfolio
  126. 8.21.5 Becton Dickinson Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst